Glenmede Trust’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Glenmede Trust’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-461	Closed	-$8K	–	2522
2018 Q1	$8K	Hold	461	–	–	﹤0.01%	2277
2017 Q4	$8K	Hold	461	–	–	﹤0.01%	2277
2017 Q3	$5K	Buy	461 +236	+105%	+$2.65K	﹤0.01%	2371
2017 Q2	$2K	Hold	225	–	–	﹤0.01%	2543
2017 Q1	$2K	Hold	225	–	–	﹤0.01%	2543
2016 Q4	$3K	Sell	225 -106	-32%	-$1.48K	﹤0.01%	2332
2016 Q3	$4K	Hold	331	–	–	﹤0.01%	2324
2016 Q2	$3K	Sell	331 -170	-34%	-$1.9K	﹤0.01%	2357
2016 Q1	$4K	Buy	501 +388	+343%	+$4.9K	﹤0.01%	2295
2015 Q4	$0	Buy	113 +57	+102%	+$1.02K	﹤0.01%	2847
2015 Q3	$1K	Buy	+56	New	+$1.28K	﹤0.01%	2657

Glenmede Trust's SCMP Position: Q2 2018 in Review

Glenmede Trust sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2018, closing a stake of 461 shares — an estimated $8K sold.

Glenmede Trust first reported a position in SCMP in Q3 2015 and held it in 11 quarters. The position peaked at $8K in Q1 2018. 0 funds tracked by Wall St. Rank hold SCMP as of Q2 2018.

Glenmede Trust reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
Glenmede Trust sold 461 Sucampo Pharmaceuticals, Inc. shares in Q2 2018, an estimated $8K.
Glenmede Trust first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 11 quarters.
Glenmede Trust's Sucampo Pharmaceuticals, Inc. position peaked at $8K in Q1 2018.
0 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2018.

Based on Glenmede Trust's 13F filing for Q2 2018, filed 15 Aug 2018.